TREACE MEDICAL CONCEPTS INC

John Treace’s insider buying signals confidence in Treace Medical Concepts’ lapiplasty, a platform‑based orthopaedic device poised to capitalize on value‑based reimbursement and digital health trends.

Treace CEO’s recent share purchase signals confidence amid FDA‑clearance hopes, 3‑D bunion tech gains momentum, and investors watch for a breakthrough.

CEO buys 154k shares of Treace Medical Concepts (TMCO), signaling confidence ahead of FDA approval for its 3‑D bunion‑correction system—could boost a $148 M small‑cap stock.

Insider sales by Treace Medical CFO amid an 82% drop highlight possible weakness—learn what it signals for investors and the company’s future.